Member Info for RegulatorUK

"I would ask then, why have they applied for MHRA self use approval for the abC-19 if it was never designed for home use."

Because they were asked to do so by the government and the Ulster study showed it could be used by members of the public.

The Grauniad also makes the claim that the Good Law Project has launched legal action against DHSC in relation to the two UK-RTC contracts. I'm not aware that this was the case - I don't think it is - so I've dropped Jo Maugham an email to ask him what the position is.

"If your not careful we end up with comments from people with limited experience of actually getting stuff done all for the sake of perfection."

I agree. Plenty of armchair experts on this BB it would appear, most of whom have a history of ****ging this share off...

"Colin and ODX reassured us multiple times. My patience is wearing thin...along with my belief that we will actually see the figures I invested for. It’s one thing to be battered by sentiment but if they have been dishonest that’s a different story."

Let's just take a step back and a deep breath...

The UK-RTC was asked to design an antibody test that could be used for surveillance studies. It was never intended to be for self-use in the home. That was a request tacked on by the government after the professional POC test was CE marked.

The simple reality is that any test that is used by the public will see a reduction in its accuracy, due to people not following the instructions correctly. Even well established LFTs like pregnancy tests have issues (particularly with negative results).

No-one has been dishonest... UK-RTC and ODX have been dealing with shifting goalposts, a statistician with a grudge and a scientifically illiterate media looking for a scandal to sell papers/provoke clicks.

"The Guardian have lost all their credibility for me during this pandemic."

The problem with the Guardian is that it no longer has credible science reporters and is too willing to rely on 'experts' like Deeks. And when they get it wrong, they no longer retract/clarify.

The Grauniad started going downhill under Rusbridger but it's descent into tabloid journalism has accelerated under Viner.

"A family member has just shown me an email from the NHS as a key worker about her antibody test come back negative. Which in the email says 'it's unlikely you have covid19 before'.

Never knew NHS were using Antibody tests yet..."

A number of NHS regions are trialling them, prior to a wider roll out early in the new year.

"Not surprising - they wouldn't be thinking about listing unless they either want to raise a large sum of money for investment or expect to make a large amount of money and want an exit strategy. It's a bullish statement for where they see business going with the antibody test
What makes you think they would be in a positi0on to takeover Omega?!"

I have to agree with you. I'm not sure why Abingdon would want to take over ODX.

Abingdon already have their own production capacity - it would make more sense to invest in increasing that, particularly given their relatively easy access to the sort of staff they need, than in a takeover.

The three listed on the gov.uk site have been listed for some time. I don't think they've published the updated lists yet.

"Becoming a PLC doesn't mean they are going public (as in shares listed on an exchange). That is an entirely different matter."

Becoming a 'plc' (please note it should always be written lower case) means that you are 'going public' - that's the whole point. You cannot be a plc and not be 'public'.

Being a plc does not automatically mean you will be listed on a stock exchange.

"...therefore *NOT* defamatory."

Damn my typing whilst doing two other things... :-)

Apologies - Paterson is not on Randox's board.... he's a "consultant" who has done a lot of lobbying of the government on their behalf.

In case anyone is worried, the fact that Randox produce a second rate test and Paterson lobbies for them are both matters of public record and therefore defamatory.

They're a company that just happens to have a former Tory Minister sitting on their board. They produce a second rate test that's being used until something better comes along (like the UK-RTC and Mologic tests).

I'm in the same position* as _TCO.

I agree with the points made! :thumbs up:

*We may even know each other IRL.

The masks are expected to go into production in Nottingham later this month and will be commercially available from December for healthcare, transport and food service settings initially.
Despite the additional layer and the antiviral properties, the masks will be in line with current Type IIR mask prices.


"It's exciting to see our technology move forward and make a real impact towards the fight against the spread of COVID-19," said Dr Cave, who is based in Nottingham Trent University's School of Science and Technology. He said: "The mask we've developed has been proven to inactivate viruses upon contact; the antiviral layer kills virus which has been blocked by the filter layers. The challenge with conventional surgical-type masks is that they only block virus from entering or exiting the mask. They don't have an active mechanism for killing it once it's trapped in the mask.

"Our new antiviral mask has been designed to utilise the existing barrier technology and combine it with our nanotechnology to kill the virus once it is trapped there.
"We've added the barrier layer to both sides of the mask so not only does it protect the wearer but also those around. By killing the virus on contact, it also means that the used face mask can be safely disposed of and not be a potential source of passive transfer."

The masks have been designed and tested following an Innovate UK grant, as part of UK Research and Innovation's response to COVID-19.

ENDS"



Notes:

See https://www.cdc.gov/coronavirus/2019-ncov/more/masking-science-sars-cov2.html

The Company notes the fast changing situation regarding possible COVID-19 vaccines. The widely reported and very positive interim trial results of a vaccine developed by Pfizer and BioNTech are hugely encouraging and welcomed by everyone. However, the Directors believe that the roll out of a vaccine will not lessen in the near term demand for its developing viricidal mask product. The Directors also note and welcome the new Scientific Brief released yesterday by the US Centre for Disease Control* expanding on the benefits of masks for both the wearer and the community.



Pharm 2 Farm is focusing on bringing its mask to market as soon as possible. The Directors' expectation is that the mask production line will be delivered and installed in its clean room facility at BioCity Nottingham at the end of this month and that production can begin shortly thereafter.



The Company also notes the announcement from Nottingham Trent University issued this morning and reproduces it in its entirety below.



"Scientists develop facemask which can kill viruses on contact

A new antiviral facemask which uses nanotechnology to kill viruses including COVID-19 and influenza has been designed and developed by a Nottingham Trent University scientist. Instead of the usual three-ply design, the five-ply surgical mask includes an additional antiviral inner layer which incorporates nano-copper created using a patented process developed at the university. The copper, which is embedded into the mask material, has ions that are emitted once in contact with a virus and this then creates an interaction with the virus's genetic material causing it to die and stop reproducing. Because they are spherical, nanoparticles have a large surface area making the approach more effective at killing the virus. The antiviral inner layer ensures additional protection for both the wearer and those in proximity.


The mask has been designed by Nottingham Trent University scientist and nanotechnology expert, Dr Gareth Cave, and is now being commercialised by NTU spin out company Pharm2Farm in Nottingham's BioCity.


The company, which was founded by Dr Cave, uses a patented process to produce and functionalise nanoparticles for a range of human, crop and animal health benefits. Tests showed that the masks, which are Type IIR - meaning they offer the highest level of protection and have a filtration efficiency of 99.98% - were highly effective, at killing more than 90% of the influenza and coronavirus over seven hours, and have been certified to ISO 18184 standards. The masks include a fluid-repellent layer on the outside - to reduce inhalation of droplets of saliva and mucus that carry COVID-19 - the antiviral nanotech layer between two filter layers, and a hypoallergenic breathable innermost layer.
While current conventional surgical masks block the virus, it can remain on or in the mask while being worn and after it has been disposed of.

This is what the authorisation covers:

http://en.china-kangjian.com/Collection-Swab-Virus-Sampling-Tube-pd6655148.html

This is not a test per se. It is an emergency use authorisation for a swab kit )which can then be used to collect a sample for analysis).

Ah - that troll's reared his head again has he?

"Regulator are you still invested in RMS?"

Yep. Still fairly confident they'll come good. I'm back in profit with them today.

I am tempted to get rid of my AVCT holding and top up my Spire Healthcare holding.

Given that the presentation was two weeks ago, Colin would have had to have a functioning crystal ball to be able to predict the vaccine announcement and give a profit warning...